Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

RecruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

October 26, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Age-Related Macular DegenerationAllergiesAlpha-Gal SyndromeAlzheimer DiseaseAmyloidosisAnkylosing SpondylitisArthritisAlopecia AreataAsthmaAtopic DermatitisAutismAutoimmune HepatitisBehcet's DiseaseBeta-ThalassemiaCancerCeliac DiseaseKidney DiseasesCOPDCrohn DiseaseCystic FibrosisDiabetesDravet SyndromeDMDFibromyalgiaGraves DiseaseThyroid DiseasesHepatitisHidradenitis SuppurativaITPLeukemiaALSLupus or SLELymphomaMultiple SclerosisMyasthenia GravisHeart DiseasesParkinson DiseasePemphigus VulgarisCirrhosisPsoriasisSchizophreniaSclerodermaSickle Cell DiseaseStrokeUlcerative ColitisVasculitisVitiligo
Interventions
DIAGNOSTIC_TEST

Specimen sample

The study may require a tissue collection and/or a participant survey for participation. Most tissue collected will come from a blood draw; up to 100mL for the health condition group, 60mL for the exceptive condition group, and up to 180mL for the control group (if determined safe for the participant). Participant surveys may involve participant reported outcomes (PROs) or custom participant surveys.

Trial Locations (1)

02451

RECRUITING

Sanguine Biosciences, Waltham

Sponsors
All Listed Sponsors
lead

Sanguine Biosciences

INDUSTRY

NCT05635266 - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | Biotech Hunter | Biotech Hunter